Skip to main content

Table 1 Tumor growth ratesa.

From: Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development

Treatment Mean tumor volume
(mm3)
Growth rate
(mm3/day)
Growth inhibition
(%)
Delay in tumor growth
(days)
pre-miR-CTRL-C4HD 683.6 ± 192.2* 26.1*   
pre-miR-16-C4HD 231.1 ± 107.9# 9.6# 66.2b 5b
  1. aGrowth rates were calculated as the slopes of growth curves. The volume, percentage of growth inhibition, and delay in tumor growth (days) in tumors from mice injected with pre-miR16-C4HD cells relative to mice injected with pre-miR-CTRL-C4HD cells were calculated at day 28, as described in Methods. *P < 0.01, **P < 0.001 versus pre-miR-CTRL-C4HD-treated cells. bRelative to pre-miR-CTRL-C4HD-treated cells, P < 0.001.
\